These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 30454850

  • 1. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
    Maki KC, Palacios OM, Buggia MA, Trivedi R, Dicklin MR, Maki CE.
    Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Novel Self-Micro-Emulsifying Delivery System Enhances Enrichment of Eicosapentaenoic Acid and Docosahexaenoic Acid after Single and Repeated Dosing in Healthy Adults in a Randomized Trial.
    West AL, Kindberg GM, Hustvedt SO, Calder PC.
    J Nutr; 2018 Nov 01; 148(11):1704-1715. PubMed ID: 30203029
    [Abstract] [Full Text] [Related]

  • 4. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid TechnologiesTM (ALT®)-based formulation.
    Lopez-Toledano MA, Thorsteinsson T, Daak AA, Maki KC, Johns C, Rabinowicz AL, Sancilio FD.
    J Clin Lipidol; 2017 Nov 01; 11(2):394-405. PubMed ID: 28502496
    [Abstract] [Full Text] [Related]

  • 5. A self-emulsifying Omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults.
    Bremmell KE, Briskey D, Meola TR, Mallard A, Prestidge CA, Rao A.
    Eur J Nutr; 2020 Sep 01; 59(6):2729-2737. PubMed ID: 31637467
    [Abstract] [Full Text] [Related]

  • 6. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid TechnologiesTM (ALT®) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza®.
    Lopez-Toledano MA, Thorsteinsson T, Daak A, Maki KC, Johns C, Rabinowicz AL, Sancilio FD.
    Clin Ther; 2017 Mar 01; 39(3):581-591. PubMed ID: 28189364
    [Abstract] [Full Text] [Related]

  • 7. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
    Dunbar RL, Gaudet D, Davidson M, Rensfeldt M, Yang H, Nilsson C, Kvarnström M, Oscarsson J.
    Lipids Health Dis; 2020 May 30; 19(1):117. PubMed ID: 32473640
    [Abstract] [Full Text] [Related]

  • 8. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
    Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF.
    J Clin Lipidol; 2012 May 30; 6(6):573-84. PubMed ID: 23312053
    [Abstract] [Full Text] [Related]

  • 9. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
    Lapointe JF, Harvey L, Aziz S, Jordan H, Hegele RA, Lemieux P.
    Clin Ther; 2019 Mar 30; 41(3):426-444. PubMed ID: 30799231
    [Abstract] [Full Text] [Related]

  • 10. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
    Offman E, Marenco T, Ferber S, Johnson J, Kling D, Curcio D, Davidson M.
    Vasc Health Risk Manag; 2013 Mar 30; 9():563-73. PubMed ID: 24124374
    [Abstract] [Full Text] [Related]

  • 11. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N.
    Lipids Health Dis; 2015 Sep 02; 14():99. PubMed ID: 26328782
    [Abstract] [Full Text] [Related]

  • 12. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial.
    Shimada H, Nilsson C, Noda Y, Kim H, Lundström T, Yajima T.
    J Atheroscler Thromb; 2017 Sep 01; 24(9):980-987. PubMed ID: 28344197
    [Abstract] [Full Text] [Related]

  • 13. A randomized trial comparing omega-3 fatty acid plasma levels after ingestion of emulsified and non-emulsified cod liver oil formulations.
    Conus N, Burgher-Kennedy N, van den Berg F, Kaur Datta G.
    Curr Med Res Opin; 2019 Apr 01; 35(4):587-593. PubMed ID: 30106311
    [Abstract] [Full Text] [Related]

  • 14. In vitro dissolution behaviour and absorption in humans of a novel mixed l-lysine salt formulation of EPA and DHA.
    Manusama K, Balvers M, Diepeveen-de Bruin M, Headley L, Bosi R, Schwarm M, Witkamp R.
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jan 01; 164():102232. PubMed ID: 33360684
    [Abstract] [Full Text] [Related]

  • 15. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil.
    Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A.
    Lipids Health Dis; 2011 Aug 22; 10():145. PubMed ID: 21854650
    [Abstract] [Full Text] [Related]

  • 16. Wax Ester Rich Oil From The Marine Crustacean, Calanus finmarchicus, is a Bioavailable Source of EPA and DHA for Human Consumption.
    Cook CM, Larsen TS, Derrig LD, Kelly KM, Tande KS.
    Lipids; 2016 Oct 22; 51(10):1137-1144. PubMed ID: 27604086
    [Abstract] [Full Text] [Related]

  • 17. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
    Cook CM, Hallaråker H, Sæbø PC, Innis SM, Kelley KM, Sanoshy KD, Berger A, Maki KC.
    Prostaglandins Leukot Essent Fatty Acids; 2016 Aug 22; 111():17-24. PubMed ID: 27151222
    [Abstract] [Full Text] [Related]

  • 18. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
    Galli C, Maggi FM, Risé P, Sirtori CR.
    Br J Clin Pharmacol; 2012 Jul 22; 74(1):60-5. PubMed ID: 22242645
    [Abstract] [Full Text] [Related]

  • 19. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers.
    Rusca A, Di Stefano AF, Doig MV, Scarsi C, Perucca E.
    Eur J Clin Pharmacol; 2009 May 22; 65(5):503-10. PubMed ID: 19148629
    [Abstract] [Full Text] [Related]

  • 20. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
    Offman E, Davidson M, Abu-Rashid M, Chai P, Nilsson C.
    Eur J Drug Metab Pharmacokinet; 2017 Oct 22; 42(5):815-825. PubMed ID: 28116646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.